Clinical trial
R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma
NCT00135499 · Lymphoma Study Association, Other · Terminated
Key facts
| NCT number | NCT00135499 |
|---|---|
| Title | R-ACVBP Versus R-CHOP in Patients Aged 60-65 With Diffuse Large B-cell Lymphoma |
| Official title | Randomized Study of ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Non Previously Treated Patients Aged From 60 to 65 Years With Diffuse Large B-Cell Lymphoma |
| Lead sponsor | Lymphoma Study Association, Other |
| Collaborators | Fondation ARC |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma, Large-Cell, Diffuse |
| Intervention type | Drug |
| Interventions | Rituximab, Doxorubicin, Cyclophosphamide, Vindesine, Bleomycin, Prednisone, Vincristine |
| Enrollment | 138 |
| Start date | Oct 16, 2001 |
| Primary completion | Apr 27, 2010 |
| Completion | Apr 27, 2010 |
| First posted | Aug 26, 2005 |
| Last update posted | Aug 23, 2018 |
| Countries | Belgium, France, Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: